DLP 60 mg (Capsule (Enteric Coated))

Unit Price: ৳ 16.00 (3 x 10: ৳ 480.00)
Strip Price: ৳ 160.00

Medicine Details

Category Details
Generic Dexlansoprazole
Company General pharmaceuticals ltd
Also available as
Dlp 30 mg capsule

Product Title

  • Dexlansoprazole Delayed-release Capsule

Categories

  • Gastrointestinal medication
  • Proton Pump Inhibitor
  • Pharmacology

Description

  • Indicated for healing erosive esophagitis
  • Suppression of gastric acid secretion
  • Oral administration
  • Dosing recommendations
  • Administration without regard to food
  • Interaction with other medications
  • Common side effects
  • Pregnancy category B
  • Precautions for special populations
  • Storage conditions

Indications

  • Healing of Erosive Esophagitis
  • Maintenance of Healed Erosive Esophagitis
  • Symptomatic Non-Erosive Gastroesophageal Reflux Disease

Pharmacology

  • Proton Pump Inhibitor
  • Specified inhibition of (H+/K+)-ATPase
  • Dual Delayed Release formulation
  • Metabolized in the liver
  • Excreted by urine
  • Plasma concentration-time profile with two distinct peaks

Dosage

  • 30 mg once daily for Maintenance of Healed erosive esophagitis
  • 30 mg once daily for Symptomatic Non-Erosive GERD
  • 60 mg once daily for Healing of erosive esophagitis
  • MUPS dosing recommendations
  • Different dosing for adults and patients 12 to 17 years of age

Administration

  • Oral administration
  • Swallowing whole
  • Alternative administration method with open capsule
  • Granules should not be chewed
  • Missed dose instructions

Interaction

  • With specific medicines including Atazanavir, Warfarin, Tacrolimus, Clopidogrel, and Methotrexate

Contraindications

  • Known hypersensitivity to any component of the formulation

Side Effects

  • Diarrhea
  • Abdominal pain
  • Nausea
  • Vomiting
  • Flatulence

Pregnancy Lactation

  • Pregnancy Category B
  • No adequate and well-controlled studies for pregnant and lactating women

Precautions Warnings

  • Gastric Malignancy
  • Clostridium difficile Associated Diarrhea
  • Bone fracture
  • Hypomagnesemia
  • Concomitant use with Methotrexate

Use in Special Populations

  • Safety and effectiveness in children below 12 years not established
  • No dose adjustment necessary for elderly and renally impaired patients
  • Consideration of maximum daily dose for moderate hepatic impairment

Overdose Effects

  • No reports of significant overdose
  • Multiple doses and single dose results

Therapeutic Class

  • Proton Pump Inhibitor

Storage Conditions

  • Store below 30°C temperature
  • Dry place
  • Protected from light
  • Keep out of reach of children

Related Brands